Your browser doesn't support javascript.
Quality of life against seasonal vs perennial allergens: ESPRINT-15 modified in the pediatric population.
López-Rodríguez, Raquel; Sanz, Juan Hidalgo; Rial, Manuel Jorge; Pérez, Beatriz Veleiro; Hernández, Jorge Suanzes; López-Silvarrey, Angel; Alonso, Margarita Vila; Vera, César García; Guerrero, María Teresa Cenarro; Velillas, Juan José Lasarte; Hernández, María Isabel Moneo; Malo, María José Sánchez; Lombardía, Carmen Rodríguez.
  • López-Rodríguez R; Allergology Section, A Coruña University Hospital Complex, Spain; rlopezr26@gmail.com.
  • Sanz JH; Pediatrics Department, Zaragoza Hospital, Spain.
  • Rial MJ; Allergology Section, A Coruña University Hospital Complex, Spain.
  • Pérez BV; Allergology Section, A Coruña University Hospital Complex, Spain.
  • Hernández JS; Department of Biostatistics, A Coruña University Hospital Complex, Spain.
  • López-Silvarrey A; Primary Care Pediatrics, A Coruña, Spain.
  • Alonso MV; Primary Care Pediatrics, A Coruña, Spain.
  • Vera CG; Primary Care Pediatrics, Zaragoza, Spain.
  • Guerrero MTC; Primary Care Pediatrics, Zaragoza, Spain.
  • Velillas JJL; Primary Care Pediatrics, Zaragoza, Spain.
  • Hernández MIM; Primary Care Pediatrics, Zaragoza, Spain.
  • Malo MJS; Primary Care Pediatrics, Zaragoza, Spain.
  • Lombardía CR; Primary Care Pediatrics, A Coruña, Spain.
Allergol Immunopathol (Madr) ; 50(5): 16-22, 2022.
Article in English | MEDLINE | ID: covidwho-2025813
ABSTRACT

INTRODUCTION:

Allergic rhinitis (AR) is a clinical syndrome characterized by IgE-mediated inflammation of the nasal mucosa. The present study investigates the quality of life (QoL) with AR among adults, using widely validated questionnaires, unlike in pediatric patients. MATERIALS AND

METHODS:

A cross-sectional descriptive observational study was conducted, analyzing the QoL of 102 children with AR aged between 10-15 years, belonging to two health centers (HC) in Zaragoza and two HC in Coruña. The comparison of means between the two groups is carried out using the Student's test or the Mann-Whitney test, considering a value of p˂0.05 to be significant.

RESULTS:

Around 102 children were studied, with a majority (59.8%) being male and a mean age of 12 years. Around 76.5% have a family history of atopy. It was found that AR is more prevalent in Zaragoza (p ˂0.005), and asthmais highly prevalent in Coruña (p ˂0.001). The most important sensitizations are pollen in Zaragoza (p ˂0.05) and dust mites in A Coruña (p ˂0.001). More treatment needs and associated comorbidities (p˂0.05) were observed in A Coruña. The results of the ESPRINT-15 show that 63% of the patients have a good QoL, 27% fair, and 8.8%, poor. Those sensitized to mites have a worse score (p = 0.02). It was found that 52% of children experienced improvement during home confinement, with no notable differences between the two populations. The use of the mask favored QoL in patients from Zaragoza (p ˂0.001).

CONCLUSION:

It was concluded that AR influences the QoL in pediatric patients. Greater QoL involvement, need for treatment, and comorbidities are observed in patients sensitized to dust mites compared to those sensitized to pollens. It was also observed that masks improved the symptoms, stopping patients being sensitized to pollens.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Allergens / Rhinitis, Allergic Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adolescent / Adult / Animals / Child / Female / Humans / Male Language: English Journal: Allergol Immunopathol (Madr) Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Allergens / Rhinitis, Allergic Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adolescent / Adult / Animals / Child / Female / Humans / Male Language: English Journal: Allergol Immunopathol (Madr) Year: 2022 Document Type: Article